期刊文献+

温控型胰岛素液体缓释肛门栓体外释放研究 被引量:2

In vitro release of thermosensitive slow-release rectal liquid suppository of insulin
下载PDF
导出
摘要 目的 用高效液相色谱法建立温控型胰岛素液体缓释肛门栓中胰岛素含量测定的方法,以察温控型胰岛素液体缓释肛门栓的体外释放特性.方法 色谱柱:Welch ultimate C18(4.6 mm×250 mm,5μm);流动相:0.2 mol/L硫酸盐缓冲液-乙腈(74∶26,乙醇胺调pH到2.3);检测波长:214 nm;柱温:40℃;流速:1 ml/min,对胰岛素含量进行测定.采用无膜释放模型、牛肠黏膜释放模型、羊肠黏膜释放模型,以胰岛素原料药为模型药物;考察温控型胰岛素液体缓释肛门栓的体外释药机制.结果 温控型胰岛素液体缓释肛门栓在1.0 ~40.0 U/ml范围内线性关系良好(r=0.999 1),平均回收率99.35%,RSD为0.79%;无膜释放:Q=0.4954t-2.6118(r=0.9977);牛肠黏膜释放:(1-Q) 1/3 =0.001 6t +2.927 4(r=0.975 5)羊肠黏膜释放:lnQ=0.878 3lnt-4.931 1(r=0.9705).结论 此方法简便,重复性好、专属性强、结果准确、可靠,适用于该制剂中胰岛素含量的测定.可考察温控型胰岛素液体缓释肛门栓机制. Objective To establish HPLC method for the content determination of insulin in thermosensitive slow-release rec- tal liquid suppository , evaluate release characteristics in vitro. Methods The separation was performed on a Welch ultimate column (4.6 mm× 250 mm ,5 μm). The mobile phase was composed of 0.2 mol/L sodium sulfate buffer ( pH was adjusted to 2.3 with etha- nolamine)-acetonitrile (74 : 26) with flow rate lml/min,detected at 214 nm, the insulin levels were determined. Adopting membrane less release model, bovine intestinal mncosa release model, the gut mucosa release model, insulin was used as model drug, drug re- lease meehanism of thermosensitive slow-release rectal liquid suppository of insulin in vitro was evaluate. Results The insulin in situ gel was linear in the range of 1.0-40.0 U/ml( r = 0. 999 1 ). The average recovery was 99.35% , RSD was 0.79 ; membrane-less re- lease:Q =0. 495 4t -2. 611 8(r =0. 997 7) ;bovine intestinal mucosa release:(1 - Q) 1/3 = 0. 001 6t + 2. 927 4(r = 0. 975 5) ;gut- mucosa release :lnQ = 0. 878 31nt - 4.931 1 ( r = 0. 970 5 ). Conclusion The method was simple, fine repeatability, sensitive, accu- rate and reliable. The method could be applicable to the preparation of the content determination of insulin and evaluate release mecha- nism thermosensitive slow-release rectal liquid suppository of insulin.
出处 《药学实践杂志》 CAS 2014年第1期56-58,67,共4页 Journal of Pharmaceutical Practice
关键词 胰岛素 无膜释放 牛肠黏膜释放 羊肠黏膜释放 Insulin in situ gel in vitro release membraneless release:release bovine intestinal mucosa release gut mucosa release
  • 相关文献

参考文献9

二级参考文献47

  • 1高斐,王东凯,罗立,徐松林,刘莱,徐飒.左氧氟沙星热敏型眼用凝胶的研制及体外释放研究[J].中国药房,2005,16(14):1057-1059. 被引量:42
  • 2Robinson JR,Mlynek GM.Bioadhesive and phase-chenge polymers for ocular drug delivery[J].Adv Drug Deliv Rev,1995,16:45-50.
  • 3Meisner D,Mezei M.Liposomc ocular delivery systems[J].Adv Drug Dellv Rev,1995,16:75-93.
  • 4Rabinovich-Guilatt L,Couvreur P,Lambert G,et al.Catiohie vectors in ocular drug delivery[J].J Drug Target,2004,12:623-633.
  • 5Cortesi R,Argnani R,Esposito E,et ak.Calionic liposomes as potential carriers for ocular administration of pep tides with antiherpetic activity[J].Int J Pharm,2006,317:90-100.
  • 6Desai SD,Blanchard J.In vitro evaluation of p luronic F127-based controlled relese ocular delivery systems for pilocarp ine[J].J Pharm Sci,1998,87:226-230.
  • 7Lederer CM Jr,Harold RE.Drop size of comer cialglaucoma medications[J].Am J Ophthalmol,1986,101(6):691.
  • 8王玮,周建平,任逢晓.双氯芬酸钠泊洛沙姆凝胶体外释放的影响因素研究[J].中国新药杂志,2007,16(15):1195-1198. 被引量:6
  • 9DESA1 S D, BLANCHARD J. In vitro evaluation of pluronic F127-based controlled release ocular delivery systems for pilocarpine [ J]. J Pharm Sci, 1998,87:226 - 230.
  • 10LEDERER C M Jr, HAROLD R E. Drop size of comer cialglaucoma medications [J]. Am J Ophthalmol, 1986, 101 (6) :691 -692.

共引文献41

同被引文献25

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部